146 related articles for article (PubMed ID: 10374333)
21. Chondroblastoma: An Update.
Chen W; DiFrancesco LM
Arch Pathol Lab Med; 2017 Jun; 141(6):867-871. PubMed ID: 28557595
[TBL] [Abstract][Full Text] [Related]
22. Osteosarcoma in blood relatives.
Longhi A; Benassi MS; Molendini L; Macchiagodena M; Picci P; Bacci G
Oncol Rep; 2001; 8(1):131-6. PubMed ID: 11115584
[TBL] [Abstract][Full Text] [Related]
23. H3F3 mutation status of giant cell tumors of the bone, chondroblastomas and their mimics: a combined high resolution melting and pyrosequencing approach.
Kervarrec T; Collin C; Larousserie F; Bouvier C; Aubert S; Gomez-Brouchet A; Marie B; Miquelestorena-Standley E; Le Nail LR; Avril P; Christophe Pagès J; de Pinieux G
Mod Pathol; 2017 Mar; 30(3):393-406. PubMed ID: 28059095
[TBL] [Abstract][Full Text] [Related]
24. The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability.
Overholtzer M; Rao PH; Favis R; Lu XY; Elowitz MB; Barany F; Ladanyi M; Gorlick R; Levine AJ
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11547-52. PubMed ID: 12972634
[TBL] [Abstract][Full Text] [Related]
25. [Correlation of telomere length and the expression of its regulating proteins in mesenchymal sarcomas].
Chi YK; Shen Q; Wang JC; Zheng XZ; Hou L; Zhang B
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):363-8. PubMed ID: 18677381
[TBL] [Abstract][Full Text] [Related]
26. [Detection of MDM 2 and p 53 genes in rhabdomyosarcoma by in situ hybridization].
Lai R; Wang Z; Zhe X
Zhonghua Bing Li Xue Za Zhi; 1998 Apr; 27(2):127-9. PubMed ID: 11244964
[TBL] [Abstract][Full Text] [Related]
27. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
[TBL] [Abstract][Full Text] [Related]
28. Giant cell rich osteosarcoma revisited-diagnostic criteria and histopathologic patterns, Ki67, CDK4, and MDM2 expression, changes in response to bisphosphonate and denosumab treatment.
Chow LT
Virchows Arch; 2016 Jun; 468(6):741-55. PubMed ID: 27003154
[TBL] [Abstract][Full Text] [Related]
29. [Comparative genomic hybridization (CGH) for detecting a heretofore undescribed amplified chromosomal segment in high-grade medullary osteosarcoma].
Brinkschmidt C; Blasius S; Bürger H; Simon R; Diallo R; Battmann A; Winkelmann W; Böcker W; Dockhorn-Dworniczak B
Verh Dtsch Ges Pathol; 1998; 82():184-8. PubMed ID: 10095431
[TBL] [Abstract][Full Text] [Related]
30. Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of bone.
Evdokiou A; Atkins GJ; Bouralexis S; Hay S; Raggatt LJ; Cowled PA; Graves SE; Clayer M; Findlay DM
Int J Oncol; 2001 Sep; 19(3):625-32. PubMed ID: 11494046
[TBL] [Abstract][Full Text] [Related]
31. Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws.
Lopes MA; Nikitakis NG; Ord RA; Sauk J
Oral Oncol; 2001 Oct; 37(7):566-71. PubMed ID: 11564577
[TBL] [Abstract][Full Text] [Related]
32. P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions.
Shooshtarizadeh T; Rahimi M; Movahedinia S
Pathol Res Pract; 2016 Oct; 212(10):876-879. PubMed ID: 27473669
[TBL] [Abstract][Full Text] [Related]
33. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas.
Cordon-Cardo C; Latres E; Drobnjak M; Oliva MR; Pollack D; Woodruff JM; Marechal V; Chen J; Brennan MF; Levine AJ
Cancer Res; 1994 Feb; 54(3):794-9. PubMed ID: 8306343
[TBL] [Abstract][Full Text] [Related]
34. Comparison of allelic losses in chondroblastoma and primary chondrosarcoma of bone and correlation with fluorescence in situ hybridization analysis.
Papachristou DJ; Goodman MA; Cieply K; Hunt JL; Rao UN
Hum Pathol; 2006 Jul; 37(7):890-8. PubMed ID: 16784990
[TBL] [Abstract][Full Text] [Related]
35. MDM2 and CDK4 expression in periosteal osteosarcoma.
Righi A; Gambarotti M; Benini S; Gamberi G; Cocchi S; Picci P; Bertoni F
Hum Pathol; 2015 Apr; 46(4):549-53. PubMed ID: 25680902
[TBL] [Abstract][Full Text] [Related]
36. p53 and mdm2 in mantle cell lymphoma in leukemic phase.
Solenthaler M; Matutes E; Brito-Babapulle V; Morilla R; Catovsky D
Haematologica; 2002 Nov; 87(11):1141-50. PubMed ID: 12414343
[TBL] [Abstract][Full Text] [Related]
37. p53 and ras mutations in Ewing's sarcoma.
Radig K; Schneider-Stock R; Röse I; Mittler U; Oda Y; Roessner A
Pathol Res Pract; 1998; 194(3):157-62. PubMed ID: 9587933
[TBL] [Abstract][Full Text] [Related]
38. MDM2 gene amplification in metastatic osteosarcoma.
Ladanyi M; Cha C; Lewis R; Jhanwar SC; Huvos AG; Healey JH
Cancer Res; 1993 Jan; 53(1):16-8. PubMed ID: 8416741
[TBL] [Abstract][Full Text] [Related]
39. Expression patterns of the p53 tumor suppressor gene and the mdm2 proto-oncogene in human meningiomas.
Pykett MJ; Landers J; George DL
J Neurooncol; 1997 Mar; 32(1):39-44. PubMed ID: 9049861
[TBL] [Abstract][Full Text] [Related]
40. Oncogene alterations in primary, recurrent, and metastatic human bone tumors.
Pompetti F; Rizzo P; Simon RM; Freidlin B; Mew DJ; Pass HI; Picci P; Levine AS; Carbone M
J Cell Biochem; 1996 Oct; 63(1):37-50. PubMed ID: 8891902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
